PEAK6 Investments’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,200
Closed -$51.1K 4104
2023
Q2
$51.1K Buy
+2,200
New +$49.8K ﹤0.01% 3439
2022
Q3
Sell
-2,200
Closed -$51.1K 5010
2022
Q2
$51.1K Sell
2,200
-3,700
-63% -$98.3K ﹤0.01% 3440
2022
Q1
$187K Buy
5,900
+600
+11% +$16.8K ﹤0.01% 3930
2021
Q4
$118K Buy
5,300
+100
+2% +$2.61K ﹤0.01% 4291
2021
Q3
$144K Sell
5,200
-4,100
-44% -$125K ﹤0.01% 4176
2021
Q2
$362K Buy
9,300
+6,200
+200% +$222K ﹤0.01% 3524
2021
Q1
$89K Buy
+3,100
New +$106K ﹤0.01% 4331
2020
Q4
Sell
-1,500
Closed -$23K 4623
2020
Q3
$23K Sell
1,500
-17,100
-92% -$359K ﹤0.01% 4117
2020
Q2
$378K Buy
18,600
+7,900
+74% +$142K ﹤0.01% 2907
2020
Q1
$111K Sell
10,700
-6,800
-39% -$190K ﹤0.01% 3241
2019
Q4
$659K Sell
17,500
-151,900
-90% -$6.83M ﹤0.01% 1800
2019
Q3
$7.8M Buy
169,400
+75,100
+80% +$3.49M 0.05% 470
2019
Q2
$4.93M Buy
94,300
+91,900
+3,829% +$5.39M 0.03% 707
2019
Q1
$165K Sell
2,400
-10,000
-81% -$670K ﹤0.01% 3028
2018
Q4
$740K Sell
12,400
-40,100
-76% -$3.46M ﹤0.01% 2026
2018
Q3
$6.08M Buy
+52,500
New +$5.92M 0.03% 688

Other funds holding CLB

PEAK6 Investments's CLB Position: Q3 2024 in Review

PEAK6 Investments reduced its Core Laboratories (CLB) stake by 66% in Q3 2024, selling an estimated $801K and leaving 20,750 shares worth $384K. The position accounts for ﹤0.01% of the portfolio, ranked #2467.

PEAK6 Investments first reported a position in CLB in Q3 2018 and has held it in 17 quarters since. The position peaked at $4.87M in Q3 2019. 191 funds tracked by Wall St. Rank hold CLB as of Q3 2024.

  • PEAK6 Investments held 20,750 shares of Core Laboratories worth $384K as of Q3 2024.
  • PEAK6 Investments sold 39,910 Core Laboratories shares in Q3 2024, an estimated $801K.
  • Core Laboratories made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2467 holding.
  • PEAK6 Investments first reported a position in Core Laboratories in Q3 2018 and has held it in 17 quarters since.
  • PEAK6 Investments's Core Laboratories position peaked at $4.87M in Q3 2019.
  • 191 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.